Sterling Pharma Solutions Ltd.
⚠️ Moderate Risk
FEI: 3002806719 • Cramlington, Northumberland • UNITED KINGDOM
FEI Number
3002806719
Location
Cramlington, Northumberland
Country
UNITED KINGDOMAddress
Sterling Place, Dudley Lane, Cramlington, Northumberland, United Kingdom
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
NEW VET DR
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the Federal Food, Drug, and Cosmetic Act in that it appears to be a new animal drug that is unsafe within the meaning of Section 512(a) of the Federal Food, Drug, and Cosmetic Act as it is not the subject of an approved new animal drug application, conditionally approved new animal drug application, or index listing, and no investigational new animal drug exemption applies.
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 8/22/2016 | 67A50RACTOPAMINE CATEGORY I, TYPE A MEDICATED ARTICLE | 72NEW VET DR | Minneapolis District Office (MIN-DO) |
| 8/22/2016 | 67A50RACTOPAMINE CATEGORY I, TYPE A MEDICATED ARTICLE | 72NEW VET DR | Minneapolis District Office (MIN-DO) |
| 8/22/2016 | 67A50RACTOPAMINE CATEGORY I, TYPE A MEDICATED ARTICLE | 72NEW VET DR | Minneapolis District Office (MIN-DO) |
| 8/22/2016 | 67A50RACTOPAMINE CATEGORY I, TYPE A MEDICATED ARTICLE | 72NEW VET DR | Minneapolis District Office (MIN-DO) |
| 8/22/2016 | 67A50RACTOPAMINE CATEGORY I, TYPE A MEDICATED ARTICLE | 72NEW VET DR | Minneapolis District Office (MIN-DO) |
| 8/22/2016 | 67A50RACTOPAMINE CATEGORY I, TYPE A MEDICATED ARTICLE | 72NEW VET DR | Minneapolis District Office (MIN-DO) |
| 8/22/2016 | 67A50RACTOPAMINE CATEGORY I, TYPE A MEDICATED ARTICLE | 72NEW VET DR | Minneapolis District Office (MIN-DO) |
| 8/22/2016 | 67A50RACTOPAMINE CATEGORY I, TYPE A MEDICATED ARTICLE | 72NEW VET DR | Minneapolis District Office (MIN-DO) |
| 8/22/2016 | 67A50RACTOPAMINE CATEGORY I, TYPE A MEDICATED ARTICLE | 72NEW VET DR | Minneapolis District Office (MIN-DO) |
| 8/22/2016 | 67A50RACTOPAMINE CATEGORY I, TYPE A MEDICATED ARTICLE | 72NEW VET DR | Minneapolis District Office (MIN-DO) |
| 5/24/2016 | 67A50RACTOPAMINE CATEGORY I, TYPE A MEDICATED ARTICLE | 72NEW VET DR | Minneapolis District Office (MIN-DO) |
| 8/27/2003 | 65BAY99MUCOLYTIC N.E.C. | 118NOT LISTED | Chicago District Office (CHI-DO) |
Frequently Asked Questions
What is Sterling Pharma Solutions Ltd.'s FDA import refusal history?
Sterling Pharma Solutions Ltd. (FEI: 3002806719) has 12 FDA import refusal record(s) in our database, spanning from 8/27/2003 to 8/22/2016.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Sterling Pharma Solutions Ltd.'s FEI number is 3002806719.
What types of violations has Sterling Pharma Solutions Ltd. received?
Sterling Pharma Solutions Ltd. has been cited for 2 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Sterling Pharma Solutions Ltd. come from?
All FDA import refusal data for Sterling Pharma Solutions Ltd. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.